Just a moment, the page is loading...

ASTELLAS-015K-CL-RA21




A Phase 2b, Randomized, Double-blind, Parallel-group, Placebo controlled, Dose-finding, Multi-center Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis in Patients who have had an Inadequate Response to Methotrexate
peficitinib hydrobromide
015K-CL-RA21
NCT01554696
EudraCT 2011-006018-15
Rheumatoid Arthritis
Phase 2
February 2020